{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:14:47Z","timestamp":1792628087352,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["694812"],"award-info":[{"award-number":["694812"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["ERC-ADG-2015"],"award-info":[{"award-number":["ERC-ADG-2015"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["P30 CA 008748"],"award-info":[{"award-number":["P30 CA 008748"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.semradonc.2019.12.003","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T02:08:23Z","timestamp":1588558103000},"page":"187-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy"],"prefix":"10.1016","volume":"30","author":[{"given":"Philippe","family":"Lambin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Relinde I.Y.","family":"Lieverse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dami\u00ebnne","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Oberije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.A.","family":"van der Wiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig J.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Deasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2019.12.003_bib0001","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0002","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0003","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.radonc.2018.05.017","article-title":"Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer","volume":"128","author":"Contreras","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0004","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2019.03.008","article-title":"Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy","volume":"135","author":"Joseph","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0005","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ijrobp.2018.04.026","article-title":"Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer","volume":"101","author":"Grassberger","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0006","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12094-018-1908-2","article-title":"The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study","volume":"21","author":"Karantanos","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0007","doi-asserted-by":"crossref","first-page":"114268","DOI":"10.18632\/oncotarget.23217","article-title":"Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors","volume":"8","author":"Diehl","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0008","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40425-018-0395-x","article-title":"Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas","volume":"6","author":"Ho","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cllc.2018.11.013","article-title":"Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer","volume":"20","author":"Suzuki","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0010","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/neuros\/nyz198","article-title":"Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy","volume":"85","author":"Kleinberg","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0012","doi-asserted-by":"crossref","first-page":"e11387","DOI":"10.1097\/MD.0000000000011387","article-title":"Association between density of tumor-infiltrating lymphocytes and prognoses of patients with gastric cancer","volume":"97","author":"Yu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0013","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10549-014-3185-2","article-title":"The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis","volume":"148","author":"Ibrahim","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?","volume":"7","author":"Menetrier-Caux","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0015","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1158\/1078-0432.CCR-14-2676","article-title":"Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects","volume":"21","author":"Zegers","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0016","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/1097-0142(197603)37:3<1417::AID-CNCR2820370324>3.0.CO;2-N","article-title":"The effect of radiation therapy on lymphocyte subpopulations in cancer patients","volume":"37","author":"Raben","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0017","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0009-9260(87)80032-6","article-title":"Changes in helper and suppressor T lymphocytes following radiotherapy for breast cancer","volume":"38","author":"Newman","year":"1987","journal-title":"Clin Radiol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0018","first-page":"36","article-title":"Blood lymphocyte subpopulations in breast cancer patients following radiotherapy","volume":"29","author":"Petrini","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.radonc.2014.09.002","article-title":"Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy","volume":"113","author":"Yang","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1434464","article-title":"Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma","volume":"7","author":"Suryadevara","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.21037\/atm.2019.07.58","article-title":"Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes","volume":"7","author":"Wang","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0022","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11060-017-2668-5","article-title":"Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy","volume":"136","author":"Lin","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0023","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","article-title":"Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy","volume":"105","author":"Ladbury","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8941260","article-title":"Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response","volume":"2016","author":"Reiser","year":"2016","journal-title":"Journal of immunology research"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0026","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0027","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0028","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4+ T cells","volume":"22","author":"Corthay","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0029","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/2326-6066.CIR-13-0216","article-title":"CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful","volume":"2","author":"Kim","year":"2014","journal-title":"Cancer immunology research"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/icb.2013.12","article-title":"Modulating T regulatory cells in cancer: how close are we?","volume":"91","author":"Banerjee","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0031","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.20012142","article-title":"Disease-associated bias in T helper type 1 (Th1)\/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma","volume":"196","author":"Tatsumi","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0032","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jso.22093","article-title":"B lymphocytes as effector cells in the immunotherapy of cancer","volume":"105","author":"Namm","year":"2012","journal-title":"Journal of surgical oncology"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0033","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12026-013-8472-1","article-title":"B cell regulation of anti-tumor immune response","volume":"57","author":"Zhang","year":"2013","journal-title":"Immunologic research"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0034","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/path.1700640403","article-title":"The sensitivity of lymphocytes to ionising radiation","volume":"64","author":"Trowell","year":"1952","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0036","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0037","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.4049\/jimmunol.169.7.3760","article-title":"Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo","volume":"169","author":"Grayson","year":"2002","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0038","first-page":"510","article-title":"Effects of radiation on survival and recovery of T lymphocyte subsets in C3H\/HeN mice","volume":"22","author":"Williams","year":"1994","journal-title":"Experimental hematology"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0039","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/09553002.2012.721050","article-title":"Lymphocyte subsets and their H2AX phosphorylation in response to in vivo irradiation in rats","volume":"89","author":"Zarybnicka","year":"2013","journal-title":"International journal of radiation biology"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0040","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4049\/jimmunol.1400434","article-title":"Histone deacetylation critically determines T cell subset radiosensitivity","volume":"193","author":"Pugh","year":"2014","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0041","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.4049\/jimmunol.1000488","article-title":"Resistance of CD45RA- T cells to apoptosis and functional impairment, and activation of tumor-antigen specific T cells during radiation therapy of prostate cancer","volume":"185","author":"Tabi","year":"2010","journal-title":"Journal of immunology"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0042","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2015.03.003","article-title":"The effect of ionizing radiation on regulatory T cells in health and disease","volume":"368","author":"Persa","year":"2015","journal-title":"Cancer letters"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0043","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00262-017-2051-6","article-title":"Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)","volume":"66","author":"Gururangan","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0044","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41419-018-1095-7","article-title":"Sensitivity of CD3\/CD28-stimulated versus non-stimulated lymphocytes to ionizing radiation and genotoxic anticancer drugs: key role of ATM in the differential radiation response","volume":"9","author":"Heylmann","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0045","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1038\/s41467-019-11906-2","article-title":"Tumor-reprogrammed resident T cells resist radiation to control tumors","volume":"10","author":"Arina","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0046","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-2478(01)00306-6","article-title":"Dose and dose rate effects of whole-body proton irradiation on leukocyte populations and lymphoid organs: part I","volume":"80","author":"Gridley","year":"2002","journal-title":"Immunology letters"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0047","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00066-005-1290-1","article-title":"Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy","volume":"181","author":"Sterzing","year":"2005","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0048","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1667\/RR1979.1","article-title":"Effects of proton radiation dose, dose rate and dose fractionation on hematopoietic cells in mice","volume":"174","author":"Ware","year":"2010","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0049","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1496881","article-title":"Impact of curative radiotherapy on the immune status of patients with localized prostate cancer","volume":"7","author":"Eckert","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00066-017-1144-7","article-title":"Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients","volume":"193","author":"Sage","year":"2017","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0051","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1158\/1078-0432.CCR-07-4462","article-title":"T-cell responses to survivin in cancer patients undergoing radiation therapy","volume":"14","author":"Schaue","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0052","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s12094-018-1851-2","article-title":"Comparative analysis of the effect of different radiotherapy regimes on lymphocyte and its subpopulations in breast cancer patients","volume":"20","author":"Yuan","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0053","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1515\/raon-2016-0050","article-title":"Dosimetric Predictors of Treatment-related Lymphopenia induced by Palliative Radiotherapy: Predictive Ability of Dose-volume Parameters based on Body Surface Contour","volume":"51","author":"Saito","year":"2017","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0054","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13014-017-0824-x","article-title":"Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma","volume":"12","author":"Liu","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","article-title":"Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?","volume":"97","author":"Chadha","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0056","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijrobp.2017.02.029","article-title":"In Reply to Yazici et al","volume":"98","author":"Chadha","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0057","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2017.11.028","article-title":"Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy","volume":"128","author":"Shiraishi","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0058","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.radonc.2018.02.025","article-title":"High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer","volume":"128","author":"Fang","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0059","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14338\/IJPT-17-00033.1","article-title":"Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation","volume":"4","author":"Fang","year":"2018","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0060","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijrobp.2019.03.007","article-title":"Radiation Toxicity in Lung Cancer Patients: The Heart of the Problem?","volume":"104","author":"Badiyan","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0061","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1158\/0008-5472.CAN-05-0786","article-title":"Radiation damage to the heart enhances early radiation-induced lung function loss","volume":"65","author":"van Luijk","year":"2005","journal-title":"Cancer research"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0062","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ijrobp.2007.05.065","article-title":"The impact of heart irradiation on dose-volume effects in the rat lung","volume":"69","author":"van Luijk","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0063","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0167-8140(87)80009-9","article-title":"Late functional, biochemical and histological changes in the rat lung after fractionated irradiation to the whole thorax","volume":"10","author":"van Rongen","year":"1987","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0064","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1016\/j.ijrobp.2012.07.2362","article-title":"Physiological interaction of heart and lung in thoracic irradiation","volume":"84","author":"Ghobadi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3578444","article-title":"Vascular response to fractionated irradiation in the rat lung","volume":"131","author":"Peterson","year":"1992","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0066","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/thoraxjnl-2011-200346","article-title":"Lung irradiation induces pulmonary vascular remodelling resembling pulmonary arterial hypertension","volume":"67","author":"Ghobadi","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0067","unstructured":"Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas. ClinicalTrials.gov. [https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01653834]"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0068","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1200\/JCO.2008.17.1314","article-title":"Association of serum interleukin-7 levels with the development of acute graft-versus-host disease","volume":"26","author":"Dean","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0069","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1128\/JVI.75.21.10319-10325.2001","article-title":"Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals","volume":"75","author":"Llano","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","article-title":"Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation","volume":"118","author":"Sini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0071","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1016\/j.prro.2019.07.010","article-title":"Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram","volume":"10","author":"van Rossum","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0072","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/0284186X.2015.1043396","article-title":"Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma","volume":"55","author":"Julie","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0073","doi-asserted-by":"crossref","first-page":"E538","DOI":"10.1016\/j.ijrobp.2019.06.2455","article-title":"Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, smoking, lung V5, and XRCC1 rs25487 genotype in lymphocytes","volume":"105","author":"Xie","year":"2019","journal-title":"Int J Radiat Oncol Phys Biol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0074","article-title":"Are unsatisfactory outcomes after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer due to treatment-related immunosuppression?","author":"Thor","year":"2019","journal-title":"Radiotherapy and Oncology in press"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.compbiomed.2018.08.018","article-title":"Robust liver vessel extraction using 3D U-Net with variant dice loss function","volume":"101","author":"Huang","year":"2018","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0076","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0971-6203.181636","article-title":"Dosimetric differences in flattened and flattening filter-free beam treatment plans","volume":"41","author":"Yan","year":"2016","journal-title":"J Med Phys"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0077","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3109\/09553002.2015.1068457","article-title":"High dose rate and flattening filter free irradiation can be safely implemented in clinical practice","volume":"91","author":"Dubois","year":"2015","journal-title":"International journal of radiation biology"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0078","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0079","first-page":"997","article-title":"Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment","volume":"119","author":"Levy","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.cji.0000210386.55951.c2","article-title":"IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells","volume":"29","author":"Rosenberg","year":"2006","journal-title":"J Immunother"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0081","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1078-0432.CCR-09-1303","article-title":"Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy","volume":"16","author":"Sportes","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0082","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/annonc\/mdv173","article-title":"ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients","volume":"26","author":"Tredan","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0083","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.mri.2015.06.016","article-title":"Intrahepatic portal vein blood volume estimated by non-contrast magnetic resonance imaging for the assessment of portal hypertension","volume":"33","author":"Aguirre-Reyes","year":"2015","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0084","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mrm.26515","article-title":"Quantitative measurement of cerebral blood volume using velocity-selective pulse trains","volume":"77","author":"Liu","year":"2017","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0085","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.6050","article-title":"A study to evaluate immunological response to PD-1 inhibition in squamous cell carcinoma of the head and neck (SCCHN) using novel PET imaging with [18F]F-AraG","volume":"36","author":"Colevas","year":"2018","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0086","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2018.12.011","article-title":"MRI commissioning of 1.5T MR-linac systems - a multi-institutional study","volume":"132","author":"Tijssen","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2019.12.003_bib0087","article-title":"Library of model implementations for sharing deep-learning image segmentation and outcomes models","volume":"773929","author":"Apte","year":"2019","journal-title":"bioRxiv"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429619300785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429619300785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:16:05Z","timestamp":1762355765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429619300785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1053429619300785"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2019.12.003","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}